节点文献

重组尿酸酶部分理化性质及其初步药效学研究

Study on Physicochemical Properties and Pharmacodynamic Action of Recombinant Uricase

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李晓娟李依芯陈建华

【Author】 LI Xiao-juan,LI Yi-xin,CHEN Jian-hua(Department of Molecular biology,China Pharmaceutical University,Nanjing 210009 China)

【机构】 中国药科大学分子生物学教研室中国药科大学分子生物学教研室 江苏南京210009江苏南京210009

【摘要】 产朊假丝酵母尿酸酶由基因工程菌表达,文章对重组蛋白的亚基相对分子质量、最适作用温度、最适作用pH及其热稳定性和pH稳定性等理化性质进行了考察。成功构建了小鼠高尿酸血症动物模型,并用于重组尿酸酶的初步体内药效学研究。结果:经SDS-PAGE检测重组尿酸酶亚基的表观相对分子质量为32.4 k。酶的最适作用温度和pH分别为40℃和8.0,且在pH6~12,温度20℃~60℃条件下比较稳定。初步体内药效学研究结果表明,重组尿酸酶可以显著降低模型小鼠体内的血尿酸水平。

【Abstract】 The uricase of Candida utilis was expressed in recombinant Escherichia coli.Its physicochemical properties and pharmacodynamic action was studied.Its subunit molecular weight was analysed by SDS-PAGE.Its optimum temperature and pH value were detected,and its thermal and pH stability were also found.A mouse hyperuricemia model was established and the pharmacodynamic action of the recombinant uricase was studied in vivo on the established model.Molecular weight of the recombinant uricase subunit was 32.4 ku in SDS-PAGE.The recombinant enzyme had the strongest reactive ability in pH 8.0 boric acid buffer at 40℃.It also showed good stability at pH 6~12,and at the temperature 20℃~60℃.The pharmacodynamic experiment showed that the recombinant uricase could greatly reduce the level of uric acid in the model mouse’s serum.

【基金】 江苏省自然科学基金资助项目(No.BK2005099)
  • 【文献出处】 药物生物技术 ,Pharmaceutical Biotechnology , 编辑部邮箱 ,2007年02期
  • 【分类号】R96
  • 【被引频次】8
  • 【下载频次】442
节点文献中: 

本文链接的文献网络图示:

本文的引文网络